RA Capital Management, L.P. 13D/13G Filings for Seres Therapeutics, Inc. (MCRB)

RA Capital Management, L.P. 13D and 13G filings for Seres Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
4:11 pm
Sale
2021-12-3113GSeres Therapeutics, Inc.
MCRB
RA Capital Management, L.P.0
0.000%
-4,702,206decrease
(Position Closed)
Filing
2021-05-05
4:39 pm
Purchase
2021-04-2713GSeres Therapeutics, Inc.
MCRB
RA Capital Management, L.P.4,702,206
5.100%
4,702,206increase
(New Position)
Filing